Novartis Malaysia assures easy access to treatments to Malaysian frontliners, at-risk communities
Novartis Malaysia Sdn Bhd continues its commitment to keeping Malaysian frontliners and at-risk communities safe during the COVID-19 pandemic by ensuring access of treatments to patients across critical therapeutic areas. From 2020 to 2021, Novartis Malaysia contributed over RM3 million, keeping nearly 210,300 frontline healthcare workers and vulnerable communities nationwide safe from the outbreak.
